DURAN Group launches anniversary campaign to celebrate 120 years of laboratory glassware

22-Jan-2013 - Germany

His invention revolutionised modern chemistry: at the end of the 19th century, Otto Schott, founder of modern glass technology and what is now SCHOTT AG, invented a laboratory glass made from borosilicate glass, a completely new type of technical glass. It was the first special glass with high resistance to chemicals, heat and temperature changes and was launched on the market in 1893 and registered under the brand name DURAN in 1938. Over the past 120 years, DURAN laboratory glassware has made its mark in the history of technology and is still used as a standard glass in laboratories, industry applica-tions and households around the world today.

120 years DURAN laboratory glassware

In 2013, the DURAN Group is celebrating the anniversary of "its" laboratory glass in German-speaking countries (Germany, Austria and Switzerland) with a campaign in the laboratory glassware sector. The creative idea: by means of a job advertisement, DURAN is searching for a laboratory employee with 120 years of experience. DURAN users are asked to photograph their oldest piece of laboratory glassware and upload it into the online anniversary gallery at www.duran-group.com/120years. The campaign will run from 2 January until 30 April 2013. All participants will be entered into a draw to win one of two Apple iPad3 devices.

Other news from the department research and development

Most read news

More news from our other portals

Fighting cancer: latest developments and advances

Last viewed contents

MedMira Extends Market Reach into Southeast Asia with Contract for One Million HIV Tests - SE Asia Latest Target Market in Growing Global Distributor Network

SAFC and Novozymes Biopharma extend joint agreement for the exclusive distribution of LONGR3 growth factor

ARIUS Research Signs Anti-Cancer Antibody Discovery Deal with Takeda - Three-Year Collaboration to look for Novel Cancer Treatments

Amorfix announces Michael Sonnenreich as new director and establishment of a scientific advisory board

ALTANA AG: Sale of pharmaceuticals business to Nycomed - Purchase price of approx. EUR4.5 billion

MediGene and The Johns Hopkins University Sign Development Collaboration for First Vaccine Candidates from MediGene's AAVLP Platform - Examination of product candidates for the prevention of HPV-associated diseases

Lexicon Genetics Initiates Clinical Trials of LX1031 for Irritable Bowel Syndrome

AMRI promotes Richard A. Saffee to Vice President and General Manager of Large Scale Manufacturing

Market Opportunities Abound for Life Science Suppliers in Multi-Billion Dollar U.S. Market for Biodefense Research

MIT biologists find that restoring the gene for cancer protein p53 slows spread of advanced tumors

Enzo Biochem Granted European Patent For Displacer Technology To Treat Gene Abnormalities - Methodology Could Make Possible Modification or Corrections of Cell Mutations

AbD Serotec Signs Agreement with Dana-Farber Cancer Institute for Anti-Infective Research